PPT-Michelle Morrow, PhD VP, Preclinical Translational Pharmacology PowerPoint Presentation

Fstar Therapeutics FS118 a Tetravalent PDL1 and LAG3 mAb 2 Bispecific to Overcome and Prevent Checkpoint Resistance CONFIDENTIAL The Evolution of Cancer Therapy

Upload by claire
Published on 2022-06-20

Presentation Embed Code

<iframe width="560" height="315" src="https://www.docslides.com/embed/921149" frameborder="0" allowfullscreen></iframe>

Download Presentation

Download Presentation The PPT/PDF document "Michelle Morrow, PhD VP, Preclinical Tra..." is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.